Page last updated: 2024-09-03

dioscin and ovalbumin

dioscin has been researched along with ovalbumin in 1 studies

Compound Research Comparison

Studies (dioscin)	Trials (dioscin)	Recent Studies (post-2010) (dioscin)	Studies (ovalbumin)	Trials (ovalbumin)	Recent Studies (post-2010) (ovalbumin)
250	0	200	19,565	63	5,664

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Qi, Y; Shang, Q; Shang, W; Zeng, J; Zhu, L	1

Other Studies

1 other study(ies) available for dioscin and ovalbumin

Article	Year
Dioscin exhibits protective effects on in vivo and in vitro asthma models via suppressing TGF-β1/Smad2/3 and AKT pathways. Journal of biochemical and molecular toxicology, 2022, Volume: 36, Issue:8 Topics: Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage Fluid; Collagen; Diosgenin; Disease Models, Animal; Humans; Hyperplasia; Immunoglobulin E; Immunoglobulin G; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Proto-Oncogene Proteins c-akt; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1	2022

Article

Year

Dioscin exhibits protective effects on in vivo and in vitro asthma models via suppressing TGF-β1/Smad2/3 and AKT pathways.

Journal of biochemical and molecular toxicology, 2022, Volume: 36, Issue:8

Topics: Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage Fluid; Collagen; Diosgenin; Disease Models, Animal; Humans; Hyperplasia; Immunoglobulin E; Immunoglobulin G; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Proto-Oncogene Proteins c-akt; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1

2022